Moderna to join Nasdaq-100 index on Oct. 9, replacing Warner Bros.
Moderna will join the Nasdaq-100 index on October 9, replacing Warner Bros. Discovery, which is being acquired by Paramount-Skydance. Moderna's shares rose 0.6% in after-hours trading. The change is due to the upcoming acquisition of Warner Bros. Discovery.
How this was made
The 30-second read
Why it matters
The addition of Moderna and removal of Warner Bros. Discovery will trigger portfolio adjustments across index‑linked funds.
Market read
Both stocks are likely to experience short‑term price moves driven by index fund rebalancing.
What to watch
Potential tax‑loss harvesting or short‑covering could offset buying pressure.
Background
Index changes are routine but can move the involved stocks due to passive‑investment flows.
Ticker impact
Moderna will join the Nasdaq-100 on Oct. 9, causing a 0.6% after‑hours price rise.
upward pressure as index funds add shares
Inclusion in a major index typically triggers demand from ETFs and index‑linked portfolios.
Warner Bros. Discovery will be removed from the Nasdaq-100 after its sale to Paramount‑Skydance.
downward pressure from index fund rebalancing
Removal from a flagship index often leads to outflows and price weakness.
Market effects
Adds a biotech heavyweight to the Nasdaq‑100, slightly raising sector weight.
U.S. equity markets may see modest index‑fund rebalancing activity.
Global ETFs tracking the Nasdaq‑100 will adjust holdings, affecting overseas investors.
Counterpoint
If the market has already priced the inclusion, the move could be muted or even reverse on profit‑taking.
Key entities
- companyModerna
Biotech firm joining the Nasdaq‑100.
- companyWarner Bros. Discovery
Media company exiting the Nasdaq‑100 after a sale.
